Tags
healthcare
medicine
drug
pharmaceutical
pharma
regulatory affairs
united kingdom
europe
australia
regulatory
row countries
mhra
tga
regulatory requirements
barriers for protein delivery
function
advantages
need
instability of protein and peptide
physicochemical properties of peptide and proteins
peptide and protein structure
uidelines
multidisciplinary g
efficacy guidelines
safety guidelines
quality guidelines
mission
introduction
See more
Presentations
(3)Likes
(3)Regulatory requirement of EU, MHRA & TGA
AshwiniBawankule
•
3 years ago
Quality by-Design (QbD) by Mr. Nitin Kadam.
Nitin Kadam
•
11 years ago
Herbal drug regulations
Dr Priyanka Goswami
•
7 years ago
Tags
healthcare
medicine
drug
pharmaceutical
pharma
regulatory affairs
united kingdom
europe
australia
regulatory
row countries
mhra
tga
regulatory requirements
barriers for protein delivery
function
advantages
need
instability of protein and peptide
physicochemical properties of peptide and proteins
peptide and protein structure
uidelines
multidisciplinary g
efficacy guidelines
safety guidelines
quality guidelines
mission
introduction
See more